tiprankstipranks
Appili Therapeutics announces FDA alignment on ATI-1801 NDA requirements
PremiumThe FlyAppili Therapeutics announces FDA alignment on ATI-1801 NDA requirements
2M ago
Aditxt Enters Major Investment Agreement with Evofem
Premium
Company Announcements
Aditxt Enters Major Investment Agreement with Evofem
2M ago
Aditxt CEO Clarifies NASDAQ Compliance and Capital Strategy
Premium
Company Announcements
Aditxt CEO Clarifies NASDAQ Compliance and Capital Strategy
2M ago
Evofem Biosciences files proxy for stockholder approval of acquisition by Aditxt
PremiumThe FlyEvofem Biosciences files proxy for stockholder approval of acquisition by Aditxt
3M ago
Aditxt, Inc. Outlines Growth Strategies at Global Investment Conference
Premium
Company Announcements
Aditxt, Inc. Outlines Growth Strategies at Global Investment Conference
3M ago
Aditxt, Evofem enter second amendment to plan of merger
Premium
The Fly
Aditxt, Evofem enter second amendment to plan of merger
3M ago
Aditxt and Evofem restate merger agreement towards September 30 closing
PremiumThe FlyAditxt and Evofem restate merger agreement towards September 30 closing
5M ago
Aditxt files $100M mixed securities shelf
Premium
The Fly
Aditxt files $100M mixed securities shelf
5M ago
Aditxt, Inc. Merger with Evofem Biosciences Falls Through
Premium
Company Announcements
Aditxt, Inc. Merger with Evofem Biosciences Falls Through
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100